Yujin powder improves large intestine dampness‐heat syndrome by regulating gut microbiota and serum metabolism

Large intestine dampness‐heat syndrome (LIDHS) is a common syndrome type in animal diarrheal diseases. Yujin powder (YJP) is one of the classic prescriptions for treating damp‐heat diarrhea. The aim of this study was to investigate the regulatory effects of YJP on gut microbiota and serum metabolism in LIDHS rats using 16S rRNA sequencing and nontargeted metabolomics. The LIDHS rat model was induced through a high‐sugar and high‐fat diet, exposure to a high‐temperature and high‐humidity environment, and infection with Escherichia coli . The results demonstrated that the administration of YJP resulted in a decrease in the abundance of Desulfovibrio , Parabacteroides , Bacteroides , Allobaculum , Escherichia , Butyricimonas , Parasutterella , and Blautia and an increase in Ruminococcus , Akkermansia , Roseburia , and Lachnoclostridium . A total of 25 potential biomarkers were identified in three groups of rats. These metabolites were primarily involved in glycerophospholipid metabolism, taurine and hypotaurine metabolism, glycerol ester metabolism, arachidonic acid metabolism, primary bile acid synthesis, and tryptophan metabolism. Our study demonstrated that YJP has the potential to alleviate LIDHS by modulating gut microbial and serum metabolic homeostasis. These results establish a foundation and offer valuable guidance for the utilization of YJP in the treatment of LIDHS.